Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Z Gastroenterol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    November 2017
  1. GROSS MJ, Harter G, Backhus J, Zizer E, et al
    Direct-acting antiviral agents in the treatment of chronic Hepatitis C - "Real-life" experience from an academic centre and two specialized clinical practices.
    Z Gastroenterol. 2017 Nov 7. doi: 10.1055/s-0043-121892.
    PubMed     Text format     Abstract available


    September 2017
  2. SCHLEVOGT B, Deterding K, Port K, Siederdissen CHZ, et al
    Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up.
    Z Gastroenterol. 2017;55:848-856.
    PubMed     Text format     Abstract available


    December 2016
  3. JOCHUM C, Maischack F, Anastasiou OE, Verheyen J, et al
    Treatment of fulminant acute Hepatitis B with nucles(t)id analogues is safe and does not lead to secondary chronification of Hepatitis B.
    Z Gastroenterol. 2016;54:1306-1311.
    PubMed     Text format     Abstract available


    November 2016
  4. WAIDMANN O, Peveling-Oberhag J, Eichler K, Schulze F, et al
    To treat or not to treat - Successful hepatitis C virus eradication in a patient with advanced hepatocellular carcinoma and complete response to sorafenib.
    Z Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  5. BECKER H, Stahmeyer JT, Manns MP, Krauth C, et al
    [Laboratory requirements to diagnose viral hepatitis under the development of guidelines].
    Z Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  6. DIKOPOULOS N, Zizer E
    [Coincidence of a chronic Hepatitis C and an autoimmune Hepatitis Type 3 - successful therapy with the new direct-acting antiviral agents].
    Z Gastroenterol. 2016;54:770-3.
    PubMed     Text format     Abstract available


  7. STAHMEYER JT, Rossol S, Bert F, Liersch S, et al
    [Costs of a guideline-based treatment of patients with chronic hepatitis C in the era of interferon-free treatment].
    Z Gastroenterol. 2016;54:760-9.
    PubMed     Text format     Abstract available


  8. HUPPE D, Buggisch P, Christensen S, Heiken H, et al
    Chronic hepatitis C patients prior to broad access to interferon-free treatments in Germany.
    Z Gastroenterol. 2016;54:740-747.
    PubMed     Text format     Abstract available


    July 2016
  9. ZIMMERMANN T, Beckebaum S, Berg C, Berg T, et al
    [Expert recommendations: Hepatitis C and transplantation].
    Z Gastroenterol. 2016;54:665-84.
    PubMed     Text format     Abstract available


    April 2016
  10. VAN HELDEN J, Weiskirchen R
    [Diagnostic value of the quantitative HBsAg determination in hepatitis B infections].
    Z Gastroenterol. 2016;54:319-26.
    PubMed     Text format     Abstract available


    March 2016
  11. KANT J, Kratzsch J, Maier M, Liebert UG, et al
    HBsAg and anti-HCV screening in elderly hospitalized patients of a German tertiary referral centre.
    Z Gastroenterol. 2016;54:231-237.
    PubMed     Text format     Abstract available


    December 2015
  12. FOERSTER F, Worns MA, Galle PR, Schattenberg JM, et al
    [Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure].
    Z Gastroenterol. 2015;53:1414-21.
    PubMed     Text format     Abstract available


  13. FOERSTER F, Worns MA, Galle PR, Schattenberg JM, et al
    [Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure].
    Z Gastroenterol. 2015;53:E2.
    PubMed     Text format    


    May 2015
  14. BERG T, Zeuzem S, Manns MP
    [Joint Statement of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Internal Medicine (DGIM) to Ledipasvir / sofosbuvir-benefit assessment according to section sign 35a SGB V the G-BA].
    Z Gastroenterol. 2015;53:519-23.
    PubMed     Text format    


    February 2015
  15. WEDEMEYER H, Zeuzem S, Manns MP
    [Joint opinion of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Internal Medicine (DGIM) to Daclatasvir-benefit assessment according to section sign 35a SGB V the G-BA].
    Z Gastroenterol. 2015;53:139-42.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: